Biological subtype, treatment response and outcomes in inflammatory breast cancer using data from the National Cancer Database.

CONCLUSION: Both treatment response and survival in patients with IBC varied with approximated biological subtype, as among other invasive breast cancers. These data support continued tailoring of systemic treatment to approximated biological subtype and highlight the recent improved outcomes in patients with HER2+ disease.
PMID: 32057107 [PubMed - as supplied by publisher]

Source: The British Journal of Surgery - February 13, 2020 Category: Surgery Authors: Kupstas AR, Hoskin TL, Day CN, Boughey JC, Habermann EB, Hieken TJ Tags: Br J Surg Source Type: research